| 摘要 |
The present invention provides a method of providing an objective, repeatable measure of the severity of an erectile dysfunction condition comprising: a) the administration in a therapeutically effective amount of a physiological mediator of penile erection, generally a vasoactive intestinal peptide (VIP) and a therapeutically effective amount of an alpha-adrenergic blocker; b) measuring the erectile response; c) grading the severity of the ED condition through the erectile response measurements. There is also provided a method of diagnosing a patient suffering from vascular ischaemia comprising:•identifying an area of the body (typically a limb) exhibiting symptoms of vascular ischaemia;•administering a therapeutically effective amount of a vasoactive intestinal peptide (VIP) and a therapeutically effective amount of an alpha-adrenergic blocker; wherein if the symptoms of vascular ischaemia are alleviated, eliminated or relieved within a predetermined period from administration, the patient is likely to be suffering from vascular ischaemia. The VIP is generally included in a composition having a pH of from around 6 to around 9. |
